Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases
Luca Fabris(University of Bergamo), Mario Strazzabosco(Yale University), Carlo Spirlı̀(Yale University), Saida Melero(University of Padua), Romina Fiorotto(University of Bergamo), Tania Roskams(KU Leuven), Massimiliano Cadamuro(University of Padua), Lajos Okolicsànyi(University of Padua), Ruth Joplin(NIHR Birmingham Liver Biomedical Research Unit), Aurelio Sonzogni(Azienda Ospedaliero Universitaria Ospedali Riuniti)
Cited by 147
Related Papers
Serum markers detect the presence of liver fibrosis: A cohort study
|Gastroenterology|2004|1.1k
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|187